Selective-bias screening nominates LabMol-394 antimalarial candidates
A machine-learning workflow guided virtual screening for parasite N-myristoyltransferase, followed by testing of selected compounds in parasite assays. The primary preprint reports a bounded set of measured antimalarial candidates, including LabMol-394, while target assignment remains computational. This is not clinical efficacy or proof of target engagement.
Technology: Selective-bias virtual screening; machine-learning target/activity models
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: Primary preprint full text reports tested selected candidates and parasite activity.
- Still unknown: Exact earliest journal version and compound prior art remain open; target-specific binding is not experimentally established.
- AI role: Model-based selective-bias workflow scores target/activity candidates for experimental testing.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10925453/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: PMC-indexed primary preprint full text; PubMed primary record/abstract and affiliations. Material checked for the specific claims stated in the record..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.